Description
HEMOGLOBIN A1C TESTING COST PER REPORTABLE
First action · last action
2012-10-01 · 2012-10-01
Transactions
1
First transaction's obligation
$36,480
Base + all options value (sum of deltas)
$36,480
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
GS07F5934R
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-10-01+$36,480= $36,480
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-10-01 | +$36,480 | $36,480 | HEMOGLOBIN A1C TESTING COST PER REPORTABLE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI J49CN39QTNW3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526F0387 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $6,895 | FY2026 |
| 36C26226P1513 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $28,264 | FY2026 |
| 36C25726F0130 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 5860 · STIMULATED COHERENT RADIATION DEVICES, COMPONENTS, AND ACCESSORIES | $18,391 | FY2026 |
| 36C24126F0141 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $182,326 | FY2026 |
| 36C25626F0181 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $111,133 | FY2026 |
| 36C24126N0855 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,989 | FY2026 |
Other recipients under Q301 from 552-DAYTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25016P0488 | ATHENA DIAGNOSTICS, INC | 552-DAYTON | $9,999 | FY2016 |
| VA25014F1316 | BIOMERIEUX INC | 552-DAYTON | $6,078 | FY2014 |
| VA25013P1020 | MYRIAD GENETIC LABORATORIES INC | 552-DAYTON | $6,764 | FY2013 |
| VA25012F0499 | POLYMEDCO LLC | 552-DAYTON | $28,980 | FY2012 |
| VA25012F0125 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 552-DAYTON | $144,211 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25013F0126_3600_GS07F5934R_4730 · retrieved 2026-09-26.